Adopting Your New Normal after a Diagnosis of Metastatic Breast Cancer
by Neal Niznan, MSW, LCSW
"Toto, I have a feeling we’re not in Kansas anymore,” Dorothy tells her little dog in the film The Wizard of Oz as she looks at the surreal landscape of Munchkin Land, realizing that the familiarity of her life has dramatically changed. Maybe you experienced a similar realization when you heard the words metastatic disease.
Partners in Survival
by Marc Heyison
“Your mother has breast cancer.” These frightening words were spoken to me in 1992. Today my mom has been cancer-free for almost 22 years. Her courage inspired me to become an advocate in the fight against breast cancer, with a mission to educate and empower men to be effective caregivers when breast cancer strikes a loved one.
Breast Cancer & Your Genes
by Kimberly I. Muse and Jennifer K. Litton, MD
Breast cancer affects approximately 232,340 women per year. Most breast cancers have various contributing factors, such as age, reproductive and menstrual history, certain changes found in the breast tissue, hormonal factors, and family history. However, about 5 to 10 percent of breast cancer cases are hereditary.
Research Presented at the 2013 Breast Cancer Symposium
The 2013 Breast Cancer Symposium was held September 7 - 9, 2013, in San Francisco, California. The Symposium was cosponsored by the American Society of Breast Disease, the American Society of Breast Surgeons, the American Society of Clinical Oncology, the American Society for Radiation Oncology, the National Consortium of Breast Centers, and the Society of Surgical Oncology.
Reclaiming Sexuality in the Face of Breast Cancer
by Michael Krychman, MD, Alyssa Dweck, MS, MD, FACOG, and Susan Kellogg Spadt, PhD, CRNP
Sexual issues are common in breast cancer survivors. Treatment, including surgery, radiation, and chemotherapy, coupled with hormonal medications and the emotional impact of the diagnosis can affect a woman’s sexual response cycle and sexual satisfaction.
FDA Approves Perjeta for Neoadjuvant Breast Cancer Treatment
The U.S. Food and Drug Administration has granted accelerated approval to Perjeta (pertuzumab) as part of a complete treatment regimen for patients with early stage breast cancer before surgery (neoadjuvant setting). Perjeta is the first FDA-approved drug for the neoadjuvant treatment of breast cancer.
After Breast Cancer
After completing treatment for breast cancer, follow-up care is important to help maintain good health, which includes managing any side effects from treatment and watching for long-term side effects (called late effects) or signs of a cancer recurrence.
When the Diagnosis is Metastatic Breast Cancer
by Hoda Badr, PhD
If you’ve been diagnosed with breast cancer, you have probably gone through treatment hoping for remission or recovery. However, if your healthcare team tells you that your cancer has metastasized, you and your partner may be facing new choices regarding your care and your future together. This can be a time of frustration, fear, poor communication, and physical discomfort. But this also can be a time of growth, meaning, and healing. By coming to understand each other’s perspective, you and your partner can begin to work as a team to navigate this experience together.